38.34USD+3.20%Mkt Cap: 4.87B $P/E: —1d ago
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia P…
Industry Peers
Health Information Servicesvs Health Information Services
P/B
Pricier
1M Perf
Lower
$28.83BUSDP/E 31.5
$13.69BUSDP/E 90.6
$10.40BUSD
$7.57BUSDP/E 33.8
$6.42BUSD
$3.94BUSDP/E 30.6
$3.24BUSDP/E 151.4
$2.53BUSD
$1.89BUSDP/E 94.4
$1.53BUSD
$1.30BUSD
$1.21BUSD
$1.02BUSD
$975.39MUSDP/E 48.0
$871.07MUSDP/E Infinity
$796.11MUSDP/E 40.7
$713.43MUSDP/E 33.6
$635.66MUSDP/E 64.3
$609.65MUSD
$563.71MUSDP/E 13.3
$581.50MUSD
$501.65MUSDP/E 28.1
$516.62MUSD
$462.84MUSDP/E 26.3
$486.12MUSDP/E 55.3
$476.60MUSD
$393.13MUSDP/E 90.4
$370.16MUSD
$282.18MUSD
$227.30MUSDP/E 13.9
$213.88MUSDP/E 17.4
$199.74MUSD
$154.92MUSDP/E 30.8
$145.80MUSDP/E 39.3
$152.38MUSD
$147.05MUSD
$134.30MUSDP/E Infinity
$119.30MUSDP/E 26.6
$107.34MUSDP/E 15.9
$90.09MUSDP/E 16.3
$87.68MUSD
$63.42MUSDP/E 11.0
$62.20MUSD
$61.11MUSDP/E 22.1
$48.56MUSDP/E 46.3
$47.87MUSDP/E 57.6
$48.26MUSD
$41.23MUSD
$41.63MUSD
$23.33MUSDP/E 55.8
$23.82MUSDP/E 23.0
$21.92MUSD
$19.31MUSD
$13.45MUSD
$13.16MUSD
$10.93MUSD
$9.67MUSDP/E 14.9
$9.47MUSD
$7.09MUSD
$6.52MUSD
$5.18MUSD
$5.62MUSD
$3.80MUSDP/E Infinity
$3.67MUSDP/E 0.0
$3.46MUSD
$3.38MUSD
$2.99MUSD
$1.44MUSDP/E Infinity
$512.9KUSDP/E 0.0
$373.4KUSD
$165.6KUSD
—
CRY
GraniteShares YieldBOOST CRCL ETF—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.5
—
Indicators:|
Key Statistics
Company
Market Cap4.87B $
Enterprise Value4.41B $
Revenue (TTM)638.78M $
Gross Profit443.88M $
Net Income (TTM)-43.54M $
Revenue/Share5.063 USD
Last Price38.34 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.2K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISINUS88025U1097
Valuation
P/E (Trailing)—
P/E (Forward)191.70
PEG—
EV/EBITDA-143.80
EV/Revenue6.90
P/S7.62
P/B6.15
EPS (TTM)-0.17
EPS (Forward)0.20
52W Range
11.1699% of range38.67
52W High38.67 USD
52W Low11.16 USD
Profitability
Gross Margin69.05%
Oper. Margin-11.30%
EBITDA Margin-4.80%
Profit Margin-6.77%
ROE-5.47%
ROA-4.18%
Growth
Revenue Growth-2.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF136.05M $
CapEx (TTM)5.93M $
FCF Margin19.50%
FCF Yield2.56%
Net Debt-458.46M $
Net Debt/EBITDA14.95
Balance Sheet
Debt/Equity0.11
Current Ratio5.90
Quick Ratio5.25
Book Value/Sh6.236 USD
Cash/Share4.252 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)27.62 USD
Upside (mean)-28.0%
Target Range20.00 USD – 40.00 USD
$20.00-28.0% to mean$40.00
# Analysts13
Ownership
Shares Out.116.88M
Float114.79M
Insiders1.67%
Institutions115.02%
Short Interest
Short Ratio6.9d
Short % Float25.85%
Short % Out.17.41%
Shares Short22.10M
Short (prev mo.)22.15M
Technical
SMA 5026.60 (+44.1%)
SMA 20019.74 (+94.2%)
Beta2.11
S&P 52W Chg20.05%
Avg Vol (30d)3.09M
Avg Vol (10d)4.10M
Technical Indicators
RSI (14)71.8
MACD2.8872
MACD Signal2.4764
MACD Hist.+0.4109
BB Upper38.29 USD
BB Middle32.63 USD
BB Lower26.97 USD
BB Width34.68%
ATR (14)2.330 USD
Vol Ratio (20d)0.83x